8legs: Paul conyngham

Your Followed Topics

#1 out of 228.7K est. views62.31%

An Australian dog owner used AI to pursue a treatment for his rescue dog's terminal cancer, aiming to sequence the tumor DNA and identify protein targets.
Paul Conyngham coordinated a project, leveraging AI to find a possible cure based on the tumor's mutations and proteins.
Rosie reportedly recovered, with Conyngham calling the outcome a success and noting improved quality of life.
Experts caution that this is a single case and not a general cancer cure for dogs or humans.

Vote 0

#2 out of 2

A Sydney tech entrepreneur helped develop an AI-assisted mRNA vaccine for a dog’s cancer.
Rosie, an eight-year-old rescue dog, received the vaccine over the 2025 Christmas break.
Researchers reported the tumour reduction as a notable prior step toward possible therapies.
Experts quoted suggest that AI-facilitated vaccine design is promising but not yet proven humanly applicable.
The project involved sequencing the dog’s DNA to identify tumour mutations for vaccine design.
University researchers at UNSW contributed to the genomic analysis behind the vaccine blueprint.
The story emphasizes potential for future human cancer therapies guided by AI.
Some scientists warned that media attention may outpace the current evidence base.
Conyngham has years of machine learning and data-analysis experience guiding the project.
The team plans a second vaccine round targeting another large tumour that did not respond.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.